PHARMA BRAND STRATEGY

Is your pharma brand strategy prepared for market shifts?

Intelligent frameworks enable smarter segmentation, agile omnichannel execution, and measurable performance. We help you embrace these frameworks to adapt faster to complex markets while maintaining your product's impact throughout its lifecycle.

How does AI empower a brand strategy to evolve with speed?

Our AI-driven insights, real-time analytics, and agile promotion tools help you break free from static planning cycles. You can accelerate new-to-brand (NTB) growth and optimize performance throughout the product lifecycle, evolving your strategy as fast as your market.

Are you losing market share to agile competitors?

Our solution helps you operationalize smarter decisions for your brand. By unifying agile execution, launch strategy, real-time intelligence, and AI-driven insights, you gain the foresight to drive performance and outpace the competition, ensuring you're always one step ahead.

Transform Your Commercial Model for Enterprise Impact

IQVIA helps shift from brand-led execution to enterprise engagement. By aligning portfolios and evolving capabilities like Strategic Account Management and Value-Based Pricing, you can meet the needs of Health Systems and Payers while driving sustained growth.

Launch a Cohesive Pharma Brand Strategy

Our approach integrates launch strategy with access, analytics, and balanced hcp engagement. We unify field deployment with digital channels to build a cohesive pharma brand strategy from launch to maturity, helping brand leaders avoid siloed planning by aligning with real-world dynamics.

Gain Real-Time Commercial Intelligence

The IQVIA Analytics Engine and Brand Analytics Platform deliver real-time life sciences analytics tailored to brand roles. From NBRx tracking to pull-through by territory, these tools provide the commercial intelligence you need to drive performance faster than traditional reporting cycles.
Iqvia Human data science

Find the Patients You’re Missing with AI

The IQVIA Brand Optimizer uses machine learning to predict patient acquisition levers and identify which prescribers, messages, and access strategies will unlock new growth. This ai-powered capability fuels more efficient pharma brand strategy planning and resource allocation.
IQVIA Outlet Management

WHITE PAPER

What verifiable methodology achieves 90% accuracy in forecasting?

Reimagine what’s possible with the NTB Forecast methodology. You can now achieve over 90% accuracy versus the 50% industry average, ensuring your launch planning and decisions are both data-driven and fully defensible to stakeholder.

IQVIA's Proven Commercial Impact

Our advanced analytics, forecasting, and launch advisory solutions deliver measurable results for pharmaceutical companies. These validated outcomes demonstrate our commitment to precision, speed, and commercial success across critical business functions.

90%+

Forecasting accuracy delivered using NTB Forecast.

20%

More new-to-brand Rx achieved in real-world case study.

5,000

Product launches in 120+ TAs supported.

Within just four weeks, integrated analytics flagged missed patient opportunities, helping us act fast and optimize our outreach.

Head of Market Access
Mid-Stage Biotech

Dig deeper into pharma brand strategy

Find webinars, primers, and articles designed to help you grow your pharma brand strategy knowledge base.

Explore the latest insights for pharma brand strategists

Pharma Brand Strategy Blog
Browse blogs on pharma brand strategy, patient needs and market forces shaping healthcare in the U.S.
Insights Library
Explore expert insights and strategic solutions driving the future of pharma brands in today’s U.S. market.

Frequently Asked Questions

Brand Optimizer combines AI-powered capabilities with unparalleled evidence and operational guidance to create a holistic framework. It focuses on patient acquisition and retention, and unlike separate, siloed analyses, it provides a comprehensive, actionable impact assessment that helps you make confident, data-driven decisions.

Our approach is unique because IQVIA combines unmatched data depth with AI-powered analytics across over 300 million anonymized patients and 30,000+ HCP data sources. We integrate strategy development, real-time execution, and performance measurement into one connected platform, ensuring seamless coordination and efficiency across the entire product lifecycle."

NTB Forecast delivers over 90% accuracy for new launch brands and over 95% for in-market brands throughout the entire product lifecycle. Unlike traditional, reactive forecasts, our unique methodology focuses on patient acquisition dynamics, directly linking promotional investments to sales optimization for superior outcomes and growth.

The BrandImpact™ score is the industry's only metric linking field activity to prescribing behavior at scale. Built from 11 key performance indicators and cross-validated against real-world prescription data, it provides you with a clear 'FICO score' for your brand's overall promotional impact and effectiveness.

IQVIA’s ProVoice captures direct prescriber feedback, giving your brand unbiased, real-world insights into the complex HCP decision-making process. These invaluable insights help you to accurately measure promotional impact, refine your brand messaging, and optimize your engagement strategies with confidence.

Contact Us